When it comes to cancer, progress is often measured not only by new treatments, but by how early the disease can be found. For Ryan Schoenfeld, Ph.D., CEO of The Mark Foundation for Cancer Research, that distinction has become a defining focus
CRB recently completed the design and construction of a large-scale facility for Grand River Aseptic Manufacturing that has been selected by the U.S. government to increase domestic pharmaceutical manufacturing for vaccines or therapeutics in the fight against COVID-19.
Johnson & Johnson’s latest climate goals build on the legacy and achievement of our previous efforts, while accelerating action as part of the larger movement by the private sector, along with governments and civil society, to ramp up the ambition and implementation of climate goals during this new UN Decade of Action.
Kohler Co. today announced the launch of Safe Water For All, an initiative to further address pressing issues around water access, quality, and conservation and broaden public awareness around water issues.
change:WATER Labs is changing the way humans process waste, and it all has to do with water. They recognized that if water is removed from human waste, all that's left is a compact solid that would be much easier to collect and sterilize.
OLON announced it will continue its collaboration with Novartis to support the Africa Sickle Cell Disease program as it expands to Kenya, Uganda and Tanzania.
Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.
New Hope Middle School officially opened its new Kodiak Calming Cove, a sensory room for children with special needs, recently, and "it'll make a big difference for students to have a safe space they can go into," said Belinda Sloan, the school's principal.
Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.
Truist Foundation is committed to Truist Financial Corporation's (NYSE: TFC) purpose to inspire and build better lives and communities. The Foundation...
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...
As sustainability leaders, we implement our sustainability strategy across all company activities along the entire value chain, from raw materials to...
Join us as we travel the world to uncover real stories of impact—from landfills and energy transition to workplace safety, emerging contaminants, and...
